1. 08 Jun 2018  |  North America  |  Market Research

    US Cardiac Troponin Diagnostics Market, Forecast to 2021

    High Prevalence of Heart Disease Propels Market Growth

    Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST s...

    $4,950.00

    Special Price $3,712.50 save 25 %

  2. 25 May 2018  |  Europe  |  Market Research

    Western European Cardiac Troponin Diagnostics Market, Forecast to 2021

    Emerging Biomarkers Disrupt and Spur Growth in the Heart Disease Segment

    Cardiac troponins have now become the gold standard for early diagnosis of acute myocardial infarction, making them indispensable for clinical diagnosis of Acute Coronary Syndrome (ACS). Cardiac troponins play a key role in minimizing hospital stays and reducing admission rate which are the biggest contributors to overall healthcare expenditure. Fo...

    $3,000.00

    Special Price $2,250.00 save 25 %

  3. 16 Apr 2018  |  Asia Pacific  |  Market Research

    Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021

    Increasing Incidence Rates of Myocardial Infarction and Aging Population in APAC Drive the Troponin Diagnostics Market

    Cardiac troponins will continue to remain the gold standard for early diagnosis of acute myocardial infarction (AMI); however, the key challenge to address is the advent of a complementary biomarker to prevent repeat diagnosis. Multiplexing platforms should be harnessed for simultaneous testing of complementary biomarkers such as H-FABP, cardiac my...

    $3,000.00

    Special Price $2,250.00 save 25 %